AR035699A1 - ASSOCIATION OF AT LEAST A PYRIDOINDOLONE DERIVATIVE, PHARMACEUTICAL COMPOSITION THAT INCLUDES AT LEAST A PYRIDOINDOLONE DERIVATIVE AND KIT FOR THE TREATMENT OF TUMOR CELL PROLIFERATION - Google Patents

ASSOCIATION OF AT LEAST A PYRIDOINDOLONE DERIVATIVE, PHARMACEUTICAL COMPOSITION THAT INCLUDES AT LEAST A PYRIDOINDOLONE DERIVATIVE AND KIT FOR THE TREATMENT OF TUMOR CELL PROLIFERATION

Info

Publication number
AR035699A1
AR035699A1 ARP020101522A AR035699A1 AR 035699 A1 AR035699 A1 AR 035699A1 AR P020101522 A ARP020101522 A AR P020101522A AR 035699 A1 AR035699 A1 AR 035699A1
Authority
AR
Argentina
Prior art keywords
pyridoindolone
derivative
group
kit
association
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Bernard Bourrie
Pierre Casellas
Jean Marie Derocq
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR035699A1 publication Critical patent/AR035699A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Asociación de al menos un derivado de piridoindolona de fórmula (1) en la cual R1 representa un átomo de hidrógeno o un grupo metilo o etilo; R2 representa un grupo metilo o etilo; o bien R1 y R2 forman juntos un grupo (CH2)3; r3 representa, o bien un grupo fenilo eventualmente substituido por un átomo de halógeno o un grupo metilo metoxi, o bien un grupo tienilo; R4 representa un átomo de hidrógeno o de cloro o un grupo metilo o metoxi; con uno (o varios) principio(s) activo(s) anticancerosos. También se divulgan una composición farmacéutica que comprende al menos un derivado de piridoindolona y su Kit para el tratamiento de la proliferación de células tumorales.Association of at least one pyridoindolone derivative of formula (1) in which R 1 represents a hydrogen atom or a methyl or ethyl group; R2 represents a methyl or ethyl group; or R1 and R2 together form a group (CH2) 3; R3 represents either a phenyl group optionally substituted by a halogen atom or a methyl methoxy group, or a thienyl group; R4 represents a hydrogen or chlorine atom or a methyl or methoxy group; with one (or several) active anti-cancer principle (s). A pharmaceutical composition comprising at least one pyridoindolone derivative and its Kit for the treatment of tumor cell proliferation is also disclosed.

ARP020101522 2001-04-27 2002-04-26 ASSOCIATION OF AT LEAST A PYRIDOINDOLONE DERIVATIVE, PHARMACEUTICAL COMPOSITION THAT INCLUDES AT LEAST A PYRIDOINDOLONE DERIVATIVE AND KIT FOR THE TREATMENT OF TUMOR CELL PROLIFERATION AR035699A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0104843 2001-04-27

Publications (1)

Publication Number Publication Date
AR035699A1 true AR035699A1 (en) 2004-06-23

Family

ID=42632454

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101522 AR035699A1 (en) 2001-04-27 2002-04-26 ASSOCIATION OF AT LEAST A PYRIDOINDOLONE DERIVATIVE, PHARMACEUTICAL COMPOSITION THAT INCLUDES AT LEAST A PYRIDOINDOLONE DERIVATIVE AND KIT FOR THE TREATMENT OF TUMOR CELL PROLIFERATION

Country Status (1)

Country Link
AR (1) AR035699A1 (en)

Similar Documents

Publication Publication Date Title
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
NO20054787D0 (en) Indene derivatives as pharmaceuticals
DK1767535T3 (en) Synthesis of epothilones, their intermediates, analogs and their use
ATE302775T1 (en) CARBOLINE DERIVATIVES
NO20071642L (en) N-Benzenesulfonyl-substituted anilino-pyrimidine analogs
EA200700901A1 (en) DERIVATIVES 2-AMIDO-4-PHENYL THIAZOLE, THEIR OBTAINING AND USE IN THERAPY
NO20061317L (en) Imidazopyridine derivatives as inducible NO synthase inhibitors
AR047817A1 (en) DERIVATIVES OF ARIL- AND HETEROARILPIPERIDINCARBOXILATOS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
DE602005027213D1 (en) NEW IMIDAZOLIDINE DERIVATIVES
DK1200426T3 (en) Substituted thien-3-yl-sulfonylamino (thio) carbonyl-thiazoline (thi) ones
DE60206911D1 (en) IMIDAZOLE-2-CARBOXYLAMIDE DERIVATIVES AS RAF KINASE INHIBITORS
ATE553106T1 (en) HETEROARYLPYRROLOPYRIDINONES AS KINASE INHIBITORS
CY1109962T1 (en) Substituted 1,4,8-Triazaspiro [4,5] DECAN-2-ONE COMPOUNDS FOR OBESITY TREATMENT
DE60333746D1 (en) thienyl compounds
AR054688A1 (en) RENT-PYRIDINS AS INHIBITORS 11-BETA DE LA DIABETES
ATE346067T1 (en) CARBOLINE DERIVATIVES
AR041053A1 (en) DERIVATIVES OF DIOXAN-2-ALQUILCARBAMATOS, ITS PREPARATION AND ITS APPLICATION OF THERAPEUTICS
AR027296A1 (en) DERIVATIVES OF 4-HETEROARIL-1,4-DIAZABICICLO [3.2.2] NONANO, ITS PREPARATION AND THERAPEUTIC APPLICATION
EA200600694A1 (en) DISULPHID, SULPHIDE, SULPHOXIDE AND SULPHONE DERIVATIVES OF CYCLIC SUGARS AND THEIR APPLICATION
NO20061344L (en) Imidazopyridine derivatives as inducible NO synthase inhibitors
NO20061316L (en) Imidazopyndin derivatives as inducible NO synthase inhibitors
EA200600601A1 (en) AMINOPYRIDINE DERIVATIVES AS AN INDUCED NO SYNTHASE INHIBITORS
ATE419242T1 (en) PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS
EA200101230A1 (en) NEW INHIBITORS OF METALLOPROTEASIS, THEIR METHOD OF OBTAINING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
AR035699A1 (en) ASSOCIATION OF AT LEAST A PYRIDOINDOLONE DERIVATIVE, PHARMACEUTICAL COMPOSITION THAT INCLUDES AT LEAST A PYRIDOINDOLONE DERIVATIVE AND KIT FOR THE TREATMENT OF TUMOR CELL PROLIFERATION

Legal Events

Date Code Title Description
FB Suspension of granting procedure